StonvexLoading…
StonvexStonvexStonvexCore line items from CSTM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $2.89B | $2.46B | $8.45B | $6.25B | $4.08B |
Operating Income | Not available | $272.00M | $408.00M | $244.00M | $118.00M |
Net Income | Not available | $199.00M | $273.00M | $161.00M | $73.00M |
EPS (Diluted) | $0.84 | $1.42 | $1.92 | $1.13 | $0.51 |
Total Assets | Not available | $5.84B | $5.35B | $5.38B | $5.37B |
Total Liabilities | Not available | $4.71B | $4.38B | $4.51B | $4.57B |
Cash & Equivalents | Not available | $143.00M | $120.00M | $122.00M | $133.00M |
Free Cash Flow OCF − CapEx | Not available | $1.00M | $159.00M | $50.00M | $26.00M |
Shares Outstanding | Not available | 136.15M | 135.42M | 142.28M | 143.17M |